Trials / Conditions / Refractory Myasthenia Gravis
Refractory Myasthenia Gravis
5 registered clinical trials studyying Refractory Myasthenia Gravis — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG) NCT07413835 | The Affiliated Hospital of Xuzhou Medical University | N/A |
| Terminated | Efficacy and Safety of HN2301 in Refractory Myasthenia Gravis(MG) NCT06965309 | Shenzhen MagicRNA Biotechnology Co., Ltd | N/A |
| Not Yet Recruiting | Allogeneic CD19-CAR-NK Cells in Patients With Refractory Myasthenia Gravis NCT07243366 | Guangdong ProCapZoom Biosciences Co., Ltd. | EARLY_Phase 1 |
| Unknown | Efficacy and Safety of Low-dose Rituximab in the Treatment of Refractory Myasthenia Gravis NCT05332587 | First Affiliated Hospital, Sun Yat-Sen University | Phase 3 |
| Completed | A Pilot Trial of Rituxan in Refractory Myasthenia Gravis NCT00619671 | University of Vermont | Phase 1 / Phase 2 |